GIM
STOK icon

Granahan Investment Management’s Stoke Therapeutics STOK Stock Holding History

Granahan Investment Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Buy
335,586
+144,189
+75% +$4.73M 0.53% 51
2025
Q4 		$6.07M Sell
191,397
-62,502
-25% -$1.88M 0.26% 92
2025
Q3 		$5.97M Sell
253,899
-278,514
-52% -$4.77M 0.24% 85
2025
Q2 		$6.04M Sell
532,413
-128,017
-19% -$1.22M 0.25% 92
2025
Q1 		$4.39M Buy
660,430
+92,741
+16% +$865K 0.22% 101
2024
Q4 		$6.26M Sell
567,689
-77,281
-12% -$949K 0.26% 92
2024
Q3 		$7.93M Buy
644,970
+46,569
+8% +$660K 0.31% 96
2024
Q2 		$8.08M Buy
598,401
+122,938
+26% +$1.66M 0.32% 89
2024
Q1 		$6.42M Sell
475,463
-662,424
-58% -$4.01M 0.23% 115
2023
Q4 		$5.99M Buy
1,137,887
+286,686
+34% +$1.23M 0.2% 122
2023
Q3 		$3.35M Buy
851,201
+318,321
+60% +$2.09M 0.12% 143
2023
Q2 		$5.66M Sell
532,880
-70,644
-12% -$752K 0.17% 127
2023
Q1 		$5.03M Buy
603,524
+53,305
+10% +$481K 0.15% 125
2022
Q4 		$5.08M Buy
550,219
+291,205
+112% +$3.03M 0.16% 129
2022
Q3 		$3.33M Buy
259,014
+60,393
+30% +$962K 0.11% 146
2022
Q2 		$2.62M Buy
+198,621
New +$3.02M 0.09% 152

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Granahan Investment Management's STOK Position: Q1 2026 in Review

Granahan Investment Management increased its Stoke Therapeutics (STOK) stake by 75% in Q1 2026, buying an estimated $4.73M and bringing the position to 335,586 shares worth $10.9M. The position accounts for 0.53% of the portfolio, ranked #51.

Granahan Investment Management first reported a position in STOK in Q2 2022 and has held it in 16 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Granahan Investment Management held 335,586 shares of Stoke Therapeutics worth $10.9M as of Q1 2026.
  • Granahan Investment Management bought 144,189 Stoke Therapeutics shares in Q1 2026, an estimated $4.73M.
  • Stoke Therapeutics made up 0.53% of Granahan Investment Management's portfolio in Q1 2026, its #51 holding.
  • Granahan Investment Management first reported a position in Stoke Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Granahan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.